Study Summary
This trial is testing if TENS, a mild electrical current applied to the skin, can help improve neuropathy symptoms for stage I-III breast cancer patients on chemotherapy.
- Chemotherapy-induced Peripheral Neuropathy
- Stage 1 Breast Cancer
- Stage IB Breast Cancer
- Stage III Breast Cancer
- Stage IIIA Breast Cancer
- Stage IIIB Breast Cancer
- Stage II Breast Cancer
- Stage IA Breast Cancer
- Breast Cancer
- Stage IIA Breast Cancer
- Stage IIB Breast Cancer
- Stage 2 Breast Cancer
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 7 Secondary · Reporting Duration: At baseline and 2 and 6 weeks
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
1 Treatment Group
Supportive Care (TENS)
1 of 1
Experimental Treatment
27 Total Participants · 1 Treatment Group
Primary Treatment: Transcutaneous Electrical Nerve Stimulation · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 0 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What is the participant capacity for this investigation?
"That is accurate. According to clinicaltrials.gov, the trial that was initially posted on October 19th 2022 is currently recruiting participants. 27 patients must be accepted from 3 separate medical centres." - Anonymous Online Contributor
Are participants currently being enrolled for this clinical investigation?
"According to the information listed on clinicaltrials.gov, the recruitment for this trial is ongoing and continues since its original posting date of October 19th 2022. The data was last revised on November 21st 202" - Anonymous Online Contributor